921MO Phase I global study of Iza-Bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with metastatic or unresectable non-small cell lung cancer (NSCLC) and other solid tumors
作者
H.A. Yu,Xiuning Le,M.L. Johnson,Nicholas O. Iannotti,A.I. Spira,Pasi Antero Janne,Muhammad Furqan,Tejas Patil,Gilberto De Lima Lopes Jr.,C.A. Perez,W. Jeff Edenfield,Siyuan Liu,Z. Piotrowska,C. Park,J.L. Zhao,Haitao Wang,G. Russo,Honglin Zhu,J. Cheng,Julio Antonio Peguero